Headlands Technologies LLC Cure Vac N.V. Transaction History
Headlands Technologies LLC
- $401 Million
- Q1 2024
A detailed history of Headlands Technologies LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Headlands Technologies LLC holds 6,120 shares of CVAC stock, worth $19,033. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,120Holding current value
$19,033% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CVAC
# of Institutions
95Shares Held
15.3MCall Options Held
31.4KPut Options Held
137K-
Israel Englander Millennium Management LLC | New York, Ny2.76MShares$8.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$6.14 Million0.0% of portfolio
-
Camber Capital Management LP Boston, MA1.75MShares$5.44 Million0.13% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.6MShares$4.97 Million5.88% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il981KShares$3.05 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $583M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...